In Successful Cancer Trial, Therapy "Dissolves" Stage IV Tumor in 3 Weeks

 
Related

Stop Everything and Watch This Disney Princess Medley

Good News
638 points

Man Gives Old Shelter Dogs Free Haircuts So They Can Finally Find Homes

Good News
326 points



Most recent

Confundieron botellas de agua con bombas y un drone estadounidense mató a 10 personas afganas

rmnoticias.com
20 points

Cantarle a la vida

Enrique TF-Relatos
10 points

El gran epidemiólogo de EEUU, Anthony Fauci, explica los próximos años con el Covid

Enrique TF-Noticias
402 points

La situación de inmigrantes indocumentados que colaboraron en las tareas de recuperación tras el 11S

rmnoticias.com
16 points

LA EDUCACION Y LA POLITICA

pensamiento Libre
90 points

Igualdad: Hazaña o puterío

Enrique TF-Relatos
8 points

Entrada forzada: Software espía de NSO Group accedió secretamente a dispositivos Apple

rmnoticias.com
14 points

Decálogo de ciberseguridad para los niños cuando estudian desde casa o en el colegio

Juan José González
80 points

¿Cómo influyen las llantas en la economía del transportador?

Tecnologia
8 points

La OMS estima que la pandemia estará controlada en marzo de 2022

Enrique TF-Noticias
356 points
SHARE
TWEET
An experimental drug combination dissolved a cancerous tumor so fast, it caught researchers completely off-guard. The two-drug combo completely eliminated a woman’s melanoma — and left her completely cancer-free — in just three weeks.

In Successful Cancer Trial, Therapy "Dissolves" Stage IV Tumor in 3 Weeks

Researchers were surprised at how well the drug combination worked, shrinking tumors at least 80% in more than half of the 142 patients in the trial. And the combination completely eradicated tumors in 22% of patients.

In the rapid recovery case, a 49-year-old woman was given the drugs to treat a large tumor on her chest. Doctors continued to monitor her after the treatment and she remains cancer-free. (The image on the left shows the cancer mass with an asterisk* and the photo on the right is magnified)

“I was astonished; I’d never seen anything like that,” Dr. Paul Chapman, head of the melanoma section at the Memorial Sloan Kettering Cancer Center in New York told Live Science. “She said the tumor had just kind of dissolved.”

Chapman was lead author of the research report published in the New England Journal of Medicine about the trial, part of research needed for the FDA to approve combined use of the drugs.

The woman, and others in the trial, were treated with a process called immunotherapy — using drugs to boost a person’s own immune system to fight cancer. It’s a relatively new approach to treating deadly melanoma.

he patients were given two FDA-approved melonoma drugs already being used to treat the cancer, but not used in combination before — ipilimumab (sold under the brand name Yervoy) and nivolumab (brand name Opdivo).

Ipilimumab allows the body to override part of the immune system, turning loose waves of immune cells to kill cancer cells. Nivolumab strengthens certain immune cells, called “T cells,” preventing them from dying and allowing them to continue attacking cancer longer.

Chapman says the tests confirm a suspicion doctors and researchers have had for a long time that the immune system can fight cancer. This research may open new doors in unleashing that potential.

Fuente: www.goodnewsnetwork.org
SHARE
TWEET
To comment you must log in with your account or sign up!
Featured content